Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -709.40% is 13% above its 1-year average of -816.47%, near the high end of its 1-year range (-3707.79%–-70.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 35.73% above its 12-month average of -1103.73%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -709.40%.
RETURN ON INVESTED CAPITAL (ROIC)
-709.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1103.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+35.73%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.40%
median of 552 covered companies
CURRENT VS SECTOR MEDIAN
-2159.60%
vs the sector median at left
Jupiter Neurosciences, Inc.
Market Cap
$1.16M
Return on Invested Capital (ROIC)
-709.40%
TTM Avg
-1103.73%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.19M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-69.60%
3Y Avg
-67.51%
5Y Avg
-50.89%
Market Cap
$1.11M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
Market Cap
$1.08M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-162.02%
3Y Avg
-321.37%
5Y Avg
-223.75%
Market Cap
$1.02M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
Market Cap
$1.31M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-750.62%
3Y Avg
-506.81%
5Y Avg
-355.90%
Market Cap
$1.38M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-214.97%
3Y Avg
-160.97%
5Y Avg
-133.06%
Market Cap
$874595.00
Return on Invested Capital (ROIC)
-78.01%
TTM Avg
-90.63%
3Y Avg
-141.82%
5Y Avg
-116.81%
Market Cap
$893920.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-416.12%
3Y Avg
-338.16%
5Y Avg
-243.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.16M | -709.40% | -1103.73% | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | -128.95% | -69.60% | -67.51% | -50.89% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | -9.45% | -4.19% | 5.39% | 5.39% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | -60.41% | -162.02% | -321.37% | -223.75% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -59.81% | -3.58% | -5.96% | -5.96% |
| Genprex, Inc. (GNPX)vs › | $1.31M | -107.08% | -750.62% | -506.81% | -355.90% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | -219.36% | -214.97% | -160.97% | -133.06% |
| Bone Biologics Corporation (BBLG)vs › | $874595.00 | -78.01% | -90.63% | -141.82% | -116.81% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | -416.12% | -338.16% | -243.59% |
| Decoy Therapeutics Inc. (DCOY)vs › | $883067.00 | -343.55% | -272.49% | -270.70% | -191.72% |
ROIC
-709.4%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -709.40% |
| 2026-03-31 | -457.32% |
| 2025-12-31 | -257.02% |
| 2025-09-30 | -3707.79% |
| 2025-06-30 | -387.12% |
| 2025-03-31 | -125.70% |
| 2024-12-31 | -70.97% |
